Issue 2/2022
Content (33 Articles)
Non-Hodgkin lymphomas and ionizing radiation: case report and review of the literature
Inge Schmitz-Feuerhake, Rainer Frentzel-Beyme, Roland Wolff
The burden of illness in patients with paroxysmal nocturnal hemoglobinuria receiving treatment with the C5-inhibitors eculizumab or ravulizumab: results from a US patient survey
David Dingli, Joana E. Matos, Kerri Lehrhaupt, Sangeeta Krishnan, Michael Yeh, Jesse Fishman, Sujata P. Sarda, Scott B. Baver
Langerhans cell histiocytosis in adults: a retrospective, single-center case series
Stefano Chiaravalli, Andrea Ferrari, Luca Bergamaschi, Nadia Puma, Giovanna Gattuso, Giovanna Sironi, Olga Nigro, Virginia Livellara, Elisabetta Schiavello, Veronica Biassoni, Marta Podda, Cristina Meazza, Filippo Spreafico, Michela Casanova, Monica Terenziani, Roberto Luksch, Maura Massimino
Endothelial dysfunction biomarkers in sickle cell disease: is there a role for ADMA and PAI-1?
Suellen Rodrigues Martins, Sílvia Letícia de Oliveira Toledo, Aislander Junio da Silva, Fernanda Santos Mendes, Marina Mendes de Oliveira, Leticia Gonçalves Resende Ferreira, Luci Maria Sant’Ana Dusse, Maria das Graças Carvalho, Danyelle Romana Alves Rios, Patrícia Nessralla Alpoim, Melina de Barros Pinheiro
The ratio of ATP11C/PLSCR1 mRNA transcripts has clinical significance in sickle cell anemia
Diego A. Pereira-Martins, Juan L. Coelho-Silva, Igor F. Domingos, Isabel Weinhäuser, Pedro L. Franca-Neto, Aderson S. Araujo, Rafael F. Franca, Marcos A. Bezerra, Antonio R. Lucena-Araujo
Pregnancy outcome in women with transfused beta-thalassemia in France
Emilie Virot, Isabelle Thuret, Sabine Jardel, Raoul Herbrecht, Florence Lachenal, François Lionnet, Marie-José Lucchini, Julie Machin, Stanislas Nimubona, Jean-Antoine Ribeil, Frederic Galacteros, Giovanna Cannas, Arnaud Hot
Genomic and clinical findings in myeloid neoplasms with PDGFRB rearrangement
Danika Di Giacomo, Martina Quintini, Valentina Pierini, Fabrizia Pellanera, Roberta La Starza, Paolo Gorello, Caterina Matteucci, Barbara Crescenzi, Paolo Fabio Fiumara, Marinella Veltroni, Erika Borlenghi, Francesco Albano, Fabio Forghieri, Monica Maccaferri, Francesca Bettelli, Mario Luppi, Antonio Cuneo, Giuseppe Rossi, Cristina Mecucci
ELN 2017 classification significantly impacts the risk of early death in acute myeloid leukemia patients receiving intensive induction chemotherapy
Naama Keren-Froim, Gabriel Heering, Gal Sharvit, Maya Zlotnik, Arnon Nagler, Avichai Shimoni, Abraham Avigdor, Jonathan Canaani
Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study
Alexandra-Cristina Paunescu, Christiane Bergman Copie, Sandra Malak, Steven Le Gouill, Vincent Ribrag, Krimo Bouabdallah, David Sibon, Gerhard Rumpold, Marie Preau, Nicolas Mounier, Corinne Haioun, Fabrice Jardin, Caroline Besson
Correction to: Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study
Alexandra‑Cristina Paunescu, Christiane Copie Bergman, Sandra Malak, Steven Le Gouill, Vincent Ribrag, Krimo Bouabdallah, David Sibon, Gerhard Rumpold, Marie Preau, Nicolas Mounier, Corinne Haioun, Fabrice Jardin, Caroline Besson
Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma
Mridula Krishnan, R. Gregory Bociek, Michelle Fanale, Swaminathan P. Iyer, Mary Jo Lechowicz, Philip J. Bierman, James O. Armitage, Matthew Lunning, Avyakta Kallam, Julie M. Vose
Somatic hypermutation profiles in stereotyped IGHV4-34 receptors from South American chronic lymphocytic leukemia patients
Carmen Stanganelli, Davi Coe Torres, Claudia Ortega, María Elena Márquez, Victoria Remedi, Juana Cabrera, Claudia Mardaraz, Camila Galvano, Andrea Krzywinski, Cecilia Lang, Lorena Zanella, Evangelina Agriello, Raimundo Bezares, Astrid Pavlovsky, Miguel A. Pavlovsky, Pablo Oppezzo, Irma Slavutsky
Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
Yu-Wen Wang, Xavier Cheng-Hong Tsai, Hsin-An Hou, Feng-Ming Tien, Jia-Hau Liu, Wen-Chien Chou, Bor-Sheng Ko, Yu-Wen Chen, Chien-Chin Lin, Chieh-Lung Cheng, Min-Yen Lo, Yun-Chu Lin, Li-Chun Lu, Shang-Ju Wu, Sung-Hsin Kuo, Ruey-Long Hong, Tai-Chung Huang, Ming Yao
The role of KIAA1191 in the necroptotic pathway of multiple myeloma
Zhao Xu, Yifeng Sun, Jifeng Jiang, Peng Liu
Outcomes of patients with multiple myeloma harboring chromosome 1q gain/amplification in the era of modern therapy
Xiao Hu, Cherng-Horng Wu, Janet M. Cowan, Raymond L. Comenzo, Cindy Varga
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first complete remission after 5-azacitidine and venetoclax: a multicenter retrospective study
Oren Pasvolsky, Shai Shimony, Ron Ram, Avichai Shimoni, Liat Shargian, Batia Avni, Ofir Wolach, Tzippy Shochat, Ronit Yerushalmi, Odelia Amit, Pia Raanani, Moshe Yeshurun
Allogeneic stem cell transplant recipients admitted to the intensive care unit during the peri-transplant period have unfavorable outcomes—results of a retrospective analysis from a German university hospital
Jorge Garcia Borrega, Jan-Michel Heger, Philipp Koehler, Udo Holtick, Michael Hallek, Christof Scheid, Boris Böll, Alexander Shimabukuro-Vornhagen, Matthias Kochanek, Dennis A. Eichenauer
Eltrombopag in the treatment of patients with persistent thrombocytopenia after haploidentical peripheral blood stem cell transplantation: a single-center experience
Fei Yan, Ning Lu, Zhenyang Gu, Wenrong Huang, Shuhong Wang, Xiaoning Gao, Liping Dou, Fei Li, Lili Wang, Meng Li, Daihong Liu, Chunji Gao
Risk factors and outcomes of cytomegalovirus infection in children post cord blood transplantation with focus on impact of graft-versus-host disease and immunosuppressants
Eun Sang Yi, Ji Won Lee, Yae-Jean Kim, Ki Woong Sung, Hong Hoe Koo, Keon Hee Yoo
Frontline-matched sibling donor transplant of aplastic anemia patients using primed versus steady-state bone marrow grafts
Riad El Fakih, Feras Alfraih, Saud Alhayli, Syed Osman Ahmed, Marwan Shaheen, Naeem Chaudhri, Fahad Alsharif, Amr Hanbali, Alfadel Alshaibani, Ahmad S. Alotaibi, Bander Alharbi, Faisal Mohammed AlYahya, Wedian M. Rawas, Emad Ghabashi, Ahmed Kotb, Tusneem Elhassan, Walid Rasheed, Hazzaa Alzahrani, Fahad Almohareb, Ali Alahmari, Mahmoud Aljurf
Rare presentation of myeloma with diffuse osteosclerotic lesions without features of POEMS
Winston Zheng, Michael Sze Yuan Low
Severe warm autoimmune hemolytic anemia in COVID-19 managed with least incompatible RBC product and glucocorticoids
Tien-Chan Hsieh, Oleg Sostin
Successful treatment by using a modified SMILE regimen and autologous hematopoietic stem cell transplantation in a pediatric primary EBV-positive nodular NK/T cell lymphoma patient
Jian Li, Juxin Ye, Yongren Wang, Jun Wang, Yongjun Fang
Treatment burden in multiple myeloma according to comorbidity in real life
Ernesto Pérez Persona, Itziar Oiartzabal Ormategui, Laida Cuevas Palomares, Ana Santamaría López, Diego Robles de Castro, Carlos Miguel de Sánchez, Miren Gabilondo Jalón, Carlos Pisón Herrero, Ariane Unamunzaga Cilaurren, Ana Vega González de Viñaspre, Jose María Guinea de Castro
Ixazomib as treatment for pyoderma gangrenosum associated with IgA smoldering multiple myeloma
David Alvarez Cespedes, Stephanie M. Gallitano, Divaya Bhutani
The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patients
William G. Dunn, Muxin S. Gu, Margarete A. Fabre, Jonathan Cooper, Josep F. Nomdedeu, Laura Koumas, Katerina Nicolaou, Jiangxiang Chi, Paul Costeas, George S. Vassiliou
Re: Risk factors and predictors of treatment responses and complications in immune thrombocytopenia
Kundan Mishra, Kamal Kant Sahu
Acute stroke in young adult secondary to moyamoya angiopathy unveiling HbE-β thalassemia
Shambaditya Das, Kousik Karmakar, Reetam Mukherjee, Sourav Panda, Souvik Dubey, Niladri Sarkar, Biman Kanti Ray
Fatal progression of bronchiolitis obliterans in spite of complete remission of follicular lymphoma and paraneoplastic pemphigus
Tomohiro Kishi, Jun Nakata, Toshimasa Yamada, Shinichi Nakatsuka, Ai Matsuura, Masaru Shibano
A case report of combined treatment of gilteritinib and LH-RH agonist for Fms-related tyrosine kinase 3 receptor mutation-positive acute myeloid leukemia and bone marrow metastasis of prostate cancer
Takashi Onaka, Aiko Kato-Ogura, Yasuyuki Otsuka, Fumie Iwai, Akihito Yonezawa
Re: Hosokawa K et al. Assay sensitivity of flow cytometric PNH analysis
Bruno Brando, Arianna Gatti
Assay sensitivity of flow cytometric PNH analysis: response to Brando and Gatti
Kohei Hosokawa, Shinji Nakao
Cytomegalovirus reactivation in patients with multiple myeloma administered daratumumab-combination regimens
Rikako Tabata, Nobue Sato, Nobuhiko Yamauchi, Yong-Mei Guo, Hirotaka Nakamura, Akihito Nagata, Chi Song-Gi, Yosuke Minami, Junichiro Yuda